Diagnostic Medical's Mid-Year Liquidity Report FY2026

Diagnostic Medical Systems disclosed its half-year results for the liquidity contract maintained by DMS Group, as of June 30, 2026. The liquidity account, managed by Natixis Oddo BHF, held 162,636 shares and €38,363 at the end of the reporting period. This marks a change from May 7, 2025, when the account contained 150,000 shares and €50,000.

Between January 1 and June 30, 2026, the company executed 751 purchase transactions and 807 sales. In terms of volume, 209,911 shares were acquired for €274,416, while 157,905 shares were sold for €210,429.

Upcoming financial announcements include the Q2 2026 revenue on July 20 and H1 2026 results on September 15. These will follow the closure of the Euronext Paris market.